Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adamis Pharmaceuticals Corp.

www.adamispharmaceuticals.com

Latest From Adamis Pharmaceuticals Corp.

Keeping Track: Flurry Of Approvals Rolls Over Into Holiday Season

The latest drug development news and highlights from our US FDA Performance Tracker.

Performance Tracker Drug Review

Keeping Track: Zelboraf Takes Breakthrough Path For Rare Blood Disease; Teva Resubmits Generic EpiPen

The latest drug development news and highlights from our US FDA Performance Tracker.

Approvals Regulation

Complex Products At US FDA: Adamis' Epi-Pen Alternative OKed; Sandoz Advair ANDA Accepted

The latest regulatory news on new versions of complex products and delivery systems from our FDA Performance Tracker.

Approvals Biosimilars

Pipeline Watch: Phase III Starts For Seres' SER-109, Leo's Tralokinumab And Alkermes' ALKS-5461

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Adamis Pharmaceuticals Corp.
  • Senior Management
  • Dennis J Carlo, PhD, Pres. & CEO
    Robert O Hopkins, VP, CFO
    Ronald B Moss, MD, CMO
    David J Marguglio, SVP, Corp. Dev.
    Gus Fernandez, PharmD, VP, Commercial Ops.
  • Contact Info
  • Adamis Pharmaceuticals Corp.
    Phone: (858) 997-2400
    11682 El Camino Real
    Ste. 300
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register